Fundings for medical technologies in January 2015 stand at $361 million, led by the $78.3 million IPO by Entellus Medical, followed by the $49.76 million funding of Humacyte, and the $31.65 million funding of CardioFocus.
Below are the top fundings for the month thus far:
|Entellus Medical, Inc., has raised $78.3 million in an initial public offering according to press reports||Minimally invasive devices for the treatment of chronic and recurring sinusitis|
|Humacyte, Inc., has raised $49.76 million of a planned $73.76 million round of funding according to a regulatory filing||Vascular grafts and other tissue-engineered grafts based on acellular extracellular matrices|
|CardioFocus, Inc., has raised $31.65 million of a planned $33.2 million round of funding according to a regulatory filing||Endoscopic ablation for the treatment of atrial fibrillation|
|Transcend Medical, Inc., has raised $29.27 million in a round of funding according to a regulatory filing||Devices for the treatment of glaucoma|
|EarlySense Ltd has rasied $20 million in funding from Samsung Electronics according to press reports||Non-contact vital signs monitoring|
|Vascular Dynamics, Inc., has raised $16.85 million in a Series B round of funding according to the company||Minimally invasive treatment of refractive or resistant hypertension|
For the complete list of medtech fundings in January 2015, see link.
For a historical list of the individual fundings in medtech, by month, since 2009, see link.